Home Medical Devices Air Way Clearance Market Size, Share and Forecast to 2031

Air Way Clearance Market

Air Way Clearance Market Size, Share & Trends Analysis Report By Type (Positive Expiratory Pressure (PEP), High-frequency Chest Wall Oscillation (HFCWO), Oscillating PEP devices, Intrapulmonary Percussive Ventilators, Mechanical Cough Assist), By Applications (Emphysema, Cystic Fibrosis, Neuromuscular, Bronchiectasis), By End-User (Hospitals and Clinics, Ambulatory Surgical Centers, Home Care Settings) and By Region(North America, Europe, APAC, Middle East and Africa, LATAM) Forecasts, 2023-2031

Report Code: SRMD54676DR
Study Period 2019-2031 CAGR 4.2%
Historical Period 2019-2021 Forecast Period 2023-2031
Base Year 2022 Base Year Market Size USD 768.87 Million
Forecast Year 2031 Forecast Year Market Size USD 1113.43 Million
Largest Market North America Fastest Growing Market Europe
The sample report only takes 30 secs to download, no need to wait longer.

Market Overview

The global air way clearance market size was valued at USD 768.87 million in 2022. It is estimated to reach USD 1,113.43 million by 2031, growing at a CAGR of 4.2% during the forecast period (2023–2031).

Airway Clearance Techniques (ACTs), a type of treatment, help people with conditions like cystic fibrosis live healthier lives. ACTs are physical or mechanical devices that control airflow internally or externally and facilitate coughing up mucus from the trachea and bronchi. These substances help to cough to eliminate the heavy, clingy lung mucus. Eliminating mucus from the airways improves lung health and reduces lung infections. These airway-clearing devices treat bronchiectasis, neuromuscular diseases, emphysema, cystic fibrosis, and other conditions. Lung health is improved, and lung infections are decreased when mucus is removed from the airways. The airway clearing systems market research includes a review of several airway clearance technologies, including positive expiratory pressure (PEP), high-frequency chest wall oscillation (HFCWO), oscillating pep devices, intrapulmonary percussive ventilators, and mechanical cough assist.


  • Positive Expiratory Pressure dominates the type segment
  • Bronchiectasis dominates the application segment
  • Home Care Settings dominates the distribution end-user segment
  • North America is the highest shareholder in the global market

Market Dynamics

Market Drivers

Increased Prevalence of Cystic Fibrosis (CF)

Cystic fibrosis incidence has significantly increased during the past few years worldwide. For instance, the Cystic Fibrosis Foundation Patient Registry estimates that in 2018 there were more than 30,000 cases of cystic fibrosis in the United States and more than 70,000 cases worldwide. Additionally, more than 75% of the 1,000 new cases of CF diagnosed each year are diagnosed before the age of two. Therefore, it is projected that the worrisome rise in the prevalence of CF worldwide would fuel demand for airway clearance devices, driving the market growth.

Increased Government Respiratory Disease Control Efforts

The global airway clearance industry is expanding rapidly due to rising healthcare spending and government efforts. The rising cost of healthcare has led to remarkable advances in treatment methods. Governments in several areas emphasize educating patients about the importance of early diagnosis and treatment to stop the spread of respiratory diseases. In addition, the UK's National Health Service (NHS) and the Department of Health's National Awareness and Early Diagnosis Initiative (NAEDI) run national initiatives to raise understanding about the signs and symptoms of COPD and asthma. Healthcare technology and airway clearance devices are two other industries that benefit from improvements.

Market Restraint

Rare Cases of Cystic Fibrosis in Developing Nations

Developing nations, including Asia-Pacific ones, are unaware that newborns with cystic fibrosis can be diagnosed. In these nations, as opposed to those in North America and Europe, CF cases are low. Even though Caucasians have a higher incidence rate than Asia-Pacific nations like India, China, and Japan, the real incidence rate is expected to be significantly lower due to disease registries. This is explained by national registries in these nations’ lack of information since newborns are not tested for CF at birth. Since individuals rather than national organizations conduct most investigations, it is more challenging to determine a consistent disease prevalence in countries without a national CF registry. Therefore, it is projected that shortly, limited knowledge of respiratory disorders like CF among developing nations will severely impede the growth of the global airway-clearing systems market.

Market Opportunities

Growth Prospects in Emerging Economies

Despite a lack of respiratory disorder awareness in emerging economies, Asia-Pacific and LAMEA are expected to offer lucrative growth opportunities for the airway clearance systems market due to improved healthcare infrastructure and rising demand for better healthcare services. In addition, the rise in respiratory illnesses such as cystic fibrosis, bronchiectasis, and asthma has increased the demand for airway clearance devices. Market growth is expected from developing nations' healthcare reforms. In developing nations like India, China, and Brazil, healthcare and airway clearance system R&D investments boost market growth.

Regional Analysis

North America Dominates the Global Market

Based on region, the global air way clearance market is bifurcated into North America, Europe, Asia-Pacific, Latin America, and the Middle East and Africa.

North America is the most significant global air way clearance market shareholder and is estimated to exhibit a CAGR of 3.51% over the forecast period. The demand for airway clearing systems is anticipated to increase because of growing cooperative efforts by the major players to enhance their product portfolios and guarantee high standards. The expansion is also expected to be fueled by increasing air pollution and cigarette exposure, which causes respiratory diseases. The American Society of Anesthesiologists (ASA) and different healthcare organizations have set strict practice criteria, and these rules, together with growing government initiatives, are projected to spur expansion. For instance, the ASA's challenging airway management recommendations offer evidence-based treatments. Furthermore, COPD is North America's third biggest cause of death, increasing the demand for airway clearance devices after cancer and cardiac disorders. Leading a sedentary lifestyle and environmental pollution are the main causes of the airways systems' expansion.

Europe is predicted to exhibit a CAGR of 4.4% over the forecast period. It is predicted to develop steadily due to the European government's increased focus on treating respiratory problems by the European government, the availability of well-established healthcare systems, and increased healthcare spending. A large increase in R & D activities for bettering airway clearance systems to treat cystic fibrosis and other respiratory ailments and continual product introductions would generate new market expansion opportunities over the forecast period. In addition, major European businesses use partnerships as their primary innovation method to deploy new airway clearance systems. These alliances are anticipated to offer businesses an advantage over rivals. The pharmaceutical industry's increased need for airway-clearing systems and the European Union's increased expenditure on healthcare-related R&D are further factors that support the growth of the airway-clearance systems market in Europe.

The Asia-Pacific market is expected to witness a surging demand during the forecast period owing to the increased spending power of consumers. The demand for healthcare infrastructure, the growth of hospitals in developing nations, the development of the R&D sector, the expansion of healthcare reforms, and technological improvements in airway clearance systems all contribute to the Asia-Pacific market expansion. Additionally, due to their large populations, the huge increase in demand for airways clearance systems, and the rise in R&D activities in the region's pharmaceutical and medical device industries, India and China are predicted to develop at the quickest CAGR throughout the projection period. In addition, the increase in per capita income in many nations, the rise in government initiatives to improve the healthcare sector, and the increased focus of top manufacturers on expanding their geographic presence in developing Asia-Pacific nations to seize potential growth opportunities in the market are the main factors fueling the growth of the airway clearance systems market in the region. Leading airway clearance manufacturers are gradually concentrating on this area for the launch of novel and more efficient technologies. Further, a rise in respiratory disorders, including asthma, COPD, and bronchiectasis, is a major driver of market expansion in this area.

Latin America accounted for over 9% of the market for airway clearing systems and is predicted to develop rapidly over the next years. This is due to the growth of the healthcare industry and the introduction of cutting-edge medical gadgets in this area. Increased R&D efforts to produce products to treat respiratory illnesses and the rising prevalence of neuromuscular and bronchiectasis diseases significantly expand the market. By 2025, Latin America's geriatric population, which is already growing quickly, is anticipated to total 100.5 million people. Asthma and neuromuscular illnesses are more common in this population, which increases the need for airway clearance systems. Due to the rise in demand for quick and cutting-edge treatment modalities in the healthcare industry, there should be lucrative prospects for market growth over the forecast period.

Report Scope

Report Metric Details
By Type
  1. Positive Expiratory Pressure (PEP)
  2. High-frequency Chest Wall Oscillation (HFCWO)
  3. Oscillating PEP devices
  4. Intrapulmonary Percussive Ventilators
  5. Mechanical Cough Assist
By Applications
  1. Emphysema
  2. Cystic Fibrosis
  3. Neuromuscular
  4. Bronchiectasis
By End-User
  1. Hospitals and Clinics
  2. Ambulatory Surgical Centers
  3. Home Care Settings
Company Profiles Hill Rom Holdings Philips Respironics Aptalis Pharma Thayer Medical Electromed Inc. General Physiotherapy Inc. Vortran Medical Technology Monaghan Medical Corporation PARI.
Geographies Covered
North America U.S. Canada
Europe U.K. Germany France Spain Italy Russia Nordic Benelux Rest of Europe
APAC China Korea Japan India Australia Taiwan South East Asia Rest of Asia-Pacific
Middle East and Africa UAE Turkey Saudi Arabia South Africa Egypt Nigeria Rest of MEA
LATAM Brazil Mexico Argentina Chile Colombia Rest of LATAM
Report Coverage Revenue Forecast, Competitive Landscape, Growth Factors, Environment & Regulatory Landscape and Trends
Need a Custom Report?

We can customize every report - free of charge - including purchasing stand-alone sections or country-level reports

Segmental Analysis

The global air way clearance market is bifurcated into type, application, and end-user.

Based on type, the global air way clearance market is bifurcated into positive expiratory pressure (PEP), high-frequency chest wall oscillation (HFCWO), oscillating pep devices, intrapulmonary percussive ventilators, and mechanical cough assist. 

The positive expiratory pressure segment dominates the global market and is expected to exhibit a CAGR of 4.1% over the forecast period. Positive expiratory pressure (PEP) is the term for breathing against resistance, typically against pursed lips or through a device. PEP is a device that the patient exhales through, typically while wearing a mask. The gadget creates pressure in the lungs to prevent the patient's airways from closing. The device's airflow helps to transfer the mucus into the wider airway. In addition, the primary driver of the market's growth is the sharp increase in the prevalence rate of cystic fibrosis. For instance, according to the U.S. Cystic Fibrosis Foundation, 30,000 people had cystic fibrosis in 2018, which increased the demand for airway-clearing devices and fueled the global market expansion. 

Based on application, the global air way clearance market is bifurcated into emphysema, cystic fibrosis, neuromuscular, and bronchiectasis.

The bronchiectasis segment owns the highest market share and is predicted to exhibit a CAGR of 4.2% over the forecast period. A persistent condition known as bronchiectasis causes the bronchial walls to thicken due to infection and inflammation. Exacerbations are periodic flare-ups of respiratory problems experienced by bronchiectasis patients. Infections and airway obstructions originate from the confluence and accumulation of germs and mucus in the lungs due to the damaged airways. Even though there is no cure for the illness, airway-clearing systems can help patients feel less inflamed. For instance, in 2016, the British Lung Foundation estimated that there were over 210,000 bronchiectasis sufferers in the UK. Likewise, bronchitis prevalence climbed by 40% over the past ten years, according to research released by the Europe PMC in 2019.

Based on end-user, the global air way clearance market is segmented into hospitals & clinics, ambulatory surgical centers, and home care settings.

The homecare setting segment dominates the global market and is predicted to exhibit a CAGR of 4.4% during the forecast period. Due to the shift in patient preference toward home care, the airway clearance market for homecare settings is predicted to expand at the quickest CAGR throughout the forecast period. Patients increasingly choose homecare goods to avoid waiting hours at hospitals and clinics. Individuals in home healthcare settings are encouraged to recover quickly and live independently. The medical device industry's technological advancements, which include portable, reusable, and affordable gadgets, are the main drivers of the home care settings market's expansion.

In addition, the main factors driving the segment's growth are consumer demands for quick, comfortable, cost-effective diagnosis and treatment. According to the Office of the Actuary at the Centers for Medicare & Medicaid Services, home care spending in the United States reached almost USD 103 billion in 2018 and is anticipated to reach USD 173 billion by 2026.

Market Size By Type

Recent Developments

  • January 2023- ABM Respiratory Care, a U.S. producer of medical devices, announced the introduction of BiWaze® Clear, a cutting-edge airway clearance system. In the hospital, post-acute setting, and at home, this ground-breaking technology can assist patients with acute and chronic respiratory disorders open and clear their lungs. The BiWaze® Clear System is intended to offer oscillating lung expansion (OLE) therapy for airway clearance.

Top Key Players

Hill Rom Holdings Philips Respironics Aptalis Pharma Thayer Medical Electromed Inc. General Physiotherapy Inc. Vortran Medical Technology Monaghan Medical Corporation PARI. Others

Frequently Asked Questions (FAQs)

How big is the air way clearance market?
The global air way clearance market size was valued at USD 768.87 million in 2022. It is estimated to reach USD 1,113.43 million by 2031, growing at a CAGR of 4.2% during the forecast period (2023–2031).
Europe has the highest growth in the global market.
Key verticals adopting the market include: Hill Rom Holdings, Philips Respironics, Aptalis Pharma, Thayer Medical, Electromed Inc., General Physiotherapy Inc., Vortran Medical Technology, Monaghan Medical Corporation, and PARI.
Increased prevalence of cystic fibrosis (cf) and increased government respiratory disease control efforts are the key drivers for the growth of the global market.
Growth prospects in emerging economies is one of the upcoming key trends in the global market.

We are featured on :